Qisda Corporation · TWSE:2352
Qisda — Q1 2018 Earnings Presentation
9 slides from Qisda's earnings presentation, May 9, 2018
Slide 1: Qisda Corporation Investor Conference: 2018 Q1 Results
Qisda Corporation Investor Conference : 2018 Q1 Results May 09, 2018
Slide 2: Safe Harbor Notice
Safe Harbor Notice We have made forward-looking statements in the presentation. Our forward-looking statements contain information regarding, among other things, our financial conditions, future expansion plans and business strategies. We have based these forward-looking statements on our current ex
Slide 3: 2018 Q1 Financial Results and Business Summary
2018 Q1 Financial Results and Business Summary
Slide 4: Statement of Comprehensive Income (Consolidated)
Statement of Comprehensive Income (Consolidated) Amount : NT$ Million 2017 Q4 2018 Q1 QoQ 2017 Q1 YoY Net Sales 37,120 100.0% 35,654 100.0% -4.0% 31,687 100.0% 12.5% Cost of Goods Sold (32,649) (31,367) (28,066) Gross Margin 4,472 12.0% 4,287 12.0% 0.0 ppt 3,621 11.4% +0.6 ppt Operating Expenses (3,
Slide 5: Statement of Comprehensive Income (Consolidated)
Statement of Comprehensive Income (Consolidated) Amount : NT$ Million 2018 2017 YoY Net Sales 35,654 100.0% 31,687 100.0% 12.5% Cost of Goods Sold (31,367) (28,066) Gross Margin 4,287 12.0% 3,621 11.4% +0.6 ppt Operating Expenses (3,432) -9.6% (2,821) -8.9% Operating Income 855 2.4% 800 2.5% -0.1 pp
Slide 6: Balance Sheet Highlights (Consolidated)
Balance Sheet Highlights (Consolidated) Amount : NT$ Million 2018.03.31 2017.12.31 2017.03.31 Cash & Equivalent 7,280 6.6% 6,637 6.1% 6,623 7.1% Accounts Receivable 27,010 24.5% 28,125 25.8% 25,028 26.9% Inventory 18,813 17.1% 20,179 18.5% 15,840 17.0% L-T Investments 19,564 17.7% 16,748 15.4% 16,07
Slide 7: Key Financial Ratios (Consolidated)
Key Financial Ratios (Consolidated) 2018.03.31 2017.12.31 2017.03.31 (a) AR Turnover (Days) 78 80 79 Inventory Turnover (Days) 57 56 53 AP Turnover (Days) 75 80 81 Cash Conversion Cycle (Days) 60 56 51 ROE (annualized) 11.6% 16.0% 15.7% Current ratio 102% 106% 106% Fin. Debt (b) / Total Assets 29% 2
Slide 8: Revenue Breakdown by Product Line
Revenue Breakdown by Product Line 100% 4% 4% 6% 6% 6% 8% 5% 5% 5% 6% 5% 6% 10% 10% 8% 8% 7% 8% 80% BBS 9% 11% 11% 10% 11% 10% Medical 13% 11% 10% 10% 11% 11% 60% Others ICT-Others 40% PRJ 59% 59% 58% 59% 60% LCD 57% 20% 0% Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 * BBS : BenQ business solution * Medical
Slide 9: Qisda Value-Up Solutions
Oisda Value-Up Solutions Qisda